Azienda Unita Sanitaria Locale Di Bologna
- Address
- lock Available on a paid plan
Cardiovascular Diseases Research
At Azienda Unita Sanitaria Locale Di Bologna, clinical trials in cardiology focus on major cardiovascular diseases such as acute coronary syndrome and acute myocardial infarction. These studies are designed to evaluate new ways to lower the risk of serious heart-related events and improve outcomes after a heart attack.
- Testing a new therapy to reduce recurrent cardiovascular events
- Evaluating treatment effectiveness after myocardial infarction
- Studying approaches to prevent major adverse heart and brain events
The site’s work in this area reflects a strong interest in improving both prevention and recovery for people with high-risk heart conditions.
Atrial Fibrillation and Stroke Prevention
Another key research area is the prevention of stroke and systemic embolism in people with atrial fibrillation. These trials compare potential new options with established treatment to see whether they can better balance protection from clot-related complications with overall safety.
- Assessing a new treatment for stroke prevention in atrial fibrillation
- Comparing effectiveness and safety against current standard care
- Supporting better risk reduction for patients prone to clotting events
This line of research is especially relevant for patients who need long-term protection from serious thromboembolic complications.
Digestive System Diseases Research
The site also supports studies in digestive system diseases, with a focus on ulcerative colitis. These trials aim to improve symptom control and help more young patients reach meaningful clinical remission while maintaining long-term disease management.
- Evaluating a new therapy for ulcerative colitis
- Measuring how well treatment improves clinical remission
- Studying better options for pediatric inflammatory bowel disease care
Work in this area highlights the broader clinical research activity at the Bologna site, extending beyond heart disease into chronic inflammatory conditions.
Acute Myocardial Infarction Response Studies
Clinical research here includes studies aimed at improving the immediate response to acute myocardial infarction. The goal is to test whether a treatment used at the first signs of symptoms can help reduce the chance of another heart attack and strengthen early intervention strategies.
- Testing a self-administered option for suspected heart attack
- Exploring faster treatment approaches in emergency cardiac care
- Supporting better outcomes for patients at risk of recurrent events
These studies reflect a practical focus on rapid care, prevention, and improved safety for people facing urgent cardiac risks.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Viatris Innovation GmbH1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Azienda Unita Sanitaria Locale Di Bologna
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3 Multicenter Study to Evaluate Efficacy, Safety, and Pharmacokinetics of Upadacitinib with Open-Label Induction, Randomized, Double-Blind Maintenance and Open-Label Long-Term Extension in Pediatric Subjects with Moderately to Severely Active Ulcerative Colitis and Inadequate Response, Intolerance, or Medical Contraindications to Corticosteroids, Immunosuppressants, and/or Biologic Therapy | AbbVie Deutschland GmbH & Co. KG | Phase III | Not Recruiting | Nov 2023 | — |
IMP list
lock Showing 1 of 9 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetylsalicylic Acid | 1 | Unknown | 2023-11-21 | 2023-11-21 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.